Apigenin Provides Structural Protection to Human Fibrinogen against Nitrosative Stress: Biochemical and Molecular Insights.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
13 May 2024
Historique:
received: 30 03 2024
revised: 26 04 2024
accepted: 27 04 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: epublish

Résumé

Peroxynitrite (ONOO Multi-approach analyses were carried out where fibrinogen was exposed to ONOO The findings demonstrate that apigenin significantly inhibits ONOO This study highlights, for the first time, the role of apigenin in structural protection of human fibrinogen against peroxynitrite-induced nitrosative damage. Our data indicate that apigenin offers structural protection to all three polypeptide chains (Aα, Bβ, and γ) of human fibrinogen. Specifically, apigenin prevents the dislocation or breakdown of the amino acids tryptophan, tyrosine, lysine, arginine, proline, and threonine and also prevents the exposure of hydrophobic sites in fibrinogen induced by ONOO

Sections du résumé

BACKGROUND BACKGROUND
Peroxynitrite (ONOO
METHODS METHODS
Multi-approach analyses were carried out where fibrinogen was exposed to ONOO
RESULTS RESULTS
The findings demonstrate that apigenin significantly inhibits ONOO
CONCLUSIONS CONCLUSIONS
This study highlights, for the first time, the role of apigenin in structural protection of human fibrinogen against peroxynitrite-induced nitrosative damage. Our data indicate that apigenin offers structural protection to all three polypeptide chains (Aα, Bβ, and γ) of human fibrinogen. Specifically, apigenin prevents the dislocation or breakdown of the amino acids tryptophan, tyrosine, lysine, arginine, proline, and threonine and also prevents the exposure of hydrophobic sites in fibrinogen induced by ONOO

Identifiants

pubmed: 38785983
pii: biom14050576
doi: 10.3390/biom14050576
pii:
doi:

Substances chimiques

Fibrinogen 9001-32-5
Apigenin 7V515PI7F6
Peroxynitrous Acid 14691-52-2
Tyrosine 42HK56048U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 223202
Pays : United Kingdom

Auteurs

Aisha Farhana (A)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Aljouf Province, Saudi Arabia.

Abdullah Alsrhani (A)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Aljouf Province, Saudi Arabia.

Yusuf Saleem Khan (YS)

Department of Anatomy, College of Medicine, University of Hail, Hail 55476, Hail Province, Saudi Arabia.

Mohammad Salahuddin (M)

Department of Physiology, College of Medicine, Jouf University, Sakaka 72388, Aljouf Province, Saudi Arabia.

Mohammed Ubaidullah Sayeed (MU)

Department of Pathology, College of Medicine, Jouf University, Sakaka 72388, Aljouf Province, Saudi Arabia.

Zafar Rasheed (Z)

Department of Pathology, College of Medicine, Qassim University, Buraidah 51452, Qassim Province, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH